Yatırımcı.AI

BISTTRYOct 9, 18:19Live

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.

MEDTR Stock Analysis and CommentaryMeditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.

Main MarketChemicals, Petroleum, Rubber and Plastics
19.620.34 (1.76%)
Volume
TRY 4.3M
Day range
19.28 – 20.00
Previous close
19.28
Market cap
TRY 2.3B

Last updated: Source: Borsa Istanbul, 15-minute delayed

Key Stats

Day range
19.2820.00
52 weeks
17.5934.33
Previous close
19.28
TRY 4.3M
Weighted avg.
19.56
TRY 2.3B
67.18
0.69
Paid-in capital
TRY 119M

My Notes

0 / 1000

MEDTR Company Profile

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades on Borsa Istanbul under the ticker MEDTR. Field of activity as filed with KAP (in Turkish): Şirketin amacı, tıbbi cihaz sayılan solunum sistemleri ve infüzyon sistemlerinin, ameliyat ipliklerinin ve biyosidal ürünlerin üretimi ve yurtiçi ve yurtdışı satışı ile ilaç hazırlama ve uygulama hizmetleri ile bu faaliyetlerde gereken teknik servis, bakım, kalibrasyon hizmetlerini vermektir.

Head office
İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak NO:29 Tire-İzmir
Chair of the board
Atilla Sevinçli
Subsidiaries and affiliates
4 companies

Shareholder structure

Atilla Sevinçli
56.38%
Mert Sevinçli
23.03%
Other
20.59%

MEDTR Price Performance

1 week
6.05%
1 month
−20.63%
3 months
−31.00%
Year to date
−31.48%
1 year
−35.64%
52-week high
34.33
52-week low
17.59
Distance from 52-week high
−42.85%
Volume vs 20-session average
0.7×
Rank among the day’s gainers
294 / 628
Rank by traded value
537 / 628

MEDTR Stock Summary (Oct 10, 2026)

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. (MEDTR) traded at TRY 19.62 as of 09/10/2026, a daily change of 1.76%. In the 09/10/2026 session, MEDTR ranked #294 among the top gainers and #537 by traded value out of 628 traded stocks. The share price changed 6.05% over the past week, −20.63% over the past month, −31.48% year to date and −35.64% over the past year. The 52-week trading range is TRY 17.59 – 34.33. The last close is 42.85% below the 52-week high. The company has a market cap of TRY 2.3B, a P/E ratio of 67.18, a P/B ratio of 0.69 and a free float of 20.21%. The stock belongs to the Chemicals, Petroleum, Rubber and Plastics sector, trades on the Main Market and is a constituent of the BIST All Shares, XTUMY, BIST Main Market, BIST Participation All indices. The average price target of 2 brokers is TRY 39.25, implying 100.05% upside from the current price (0 buy, 2 hold, 0 sell). Our AI fair value model estimates TRY 25.36 (29.26%); model date July 21, 2026. Technically the trend is classified as bearish and momentum as oversold. Latest KAP disclosure (October 2, 2026): Likidite Sağlayıcılık Kapsamındaki İşlemler.

Upside to the average analyst target: 100.05%. Not investment advice.

Frequently Asked Questions

2 brokers rate it 0 buy, 2 hold, 0 sell, with an average target of TRY 39.25 (100.05% upside). This data is for information only as of Oct 10, 2026; it is not investment advice.

As of August 18, 2026, the average target of 2 brokers for MEDTR is TRY 39.25; the highest target is TRY 40.00 and the lowest is TRY 38.50. Our AI fair value model estimates TRY 25.36 (29.26%).

In the 09/10/2026 session MEDTR traded at TRY 19.62, a daily change of 1.76%, with a day range of TRY 19.28 – 20.00 and a turnover of TRY 4.3M. Previous close: TRY 19.28. Data is delayed by 15 minutes.

MEDTR (Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş.) is at TRY 19.62 as of 09/10/2026, a daily change of 1.76%. Prices are delayed by 15 minutes; live prices require a Plus membership.

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades on Borsa Istanbul under the ticker MEDTR. Field of activity as filed with KAP (in Turkish): Şirketin amacı, tıbbi cihaz sayılan solunum sistemleri ve infüzyon sistemlerinin, ameliyat ipliklerinin ve biyosidal ürünlerin üretimi ve yurtiçi ve yurtdışı satışı ile ilaç hazırlama ve uygulama hizmetleri ile bu faaliyetlerde gereken teknik servis, bakım, kalibrasyon hizmetlerini vermektir. Head office: İbni Melek Osb Mahallesi Tosbi Yol 4 Sokak NO:29 Tire-İzmir. Chair of the board: Atilla Sevinçli.

According to the capital structure filed with KAP, the shareholders of MEDTR are: Atilla Sevinçli (56.38%), Mert Sevinçli (23.03%), Other (20.59%).

The share price changed 6.05% over the past week, −20.63% over the past month, −31.48% year to date and −35.64% over the past year. The 52-week trading range is TRY 17.59 – 34.33. The last close is 42.85% below the 52-week high.

MEDTR has a market cap of TRY 2.3B, a P/E ratio of 67.18, a P/B ratio of 0.69 and an EV/EBITDA of 7.70. Ratios use the latest reported financial statements and the current price.

Meditera Tıbbi Malzeme Sanayi ve Ticaret A.Ş. trades in the Chemicals, Petroleum, Rubber and Plastics sector on the Main Market market. Its indices: BIST All Shares, XTUMY, BIST Main Market, BIST Participation All, BIST Industrials, XSINS, BIST Chemicals, Petroleum, Plastics, XSIZM.

Yes. As of Oct 10, 2026, MEDTR is a constituent of the Borsa Istanbul participation indices, which cover companies that comply with interest-free finance principles: BIST Participation All. The current index period is October 2026–April 2027. Borsa Istanbul reviews participation index membership for the May–September and October–April periods; this is not investment advice.

The trailing dividend yield of MEDTR is calculated at 0.44%.

Our fair value model estimates TRY 25.36 for MEDTR, a difference of 29.26% from the current price. The model was updated on July 21, 2026. This is not investment advice.

Stocks trading alongside MEDTR in the Chemicals, Petroleum, Rubber and Plastics sector: TUPRS, GUBRF, SASA, PETKM, ECILC, AKSA, ORZAX, BRISA.

Price, ratio and company data come from IdealData, a licensed Borsa Istanbul data vendor; analyst targets from broker research; AI indicators from Yatırımcı.AI models. Prices are delayed 15 minutes, ratios refresh daily and financial statements after each KAP disclosure.

Participation index coverage: Borsa Istanbul

Prepared by: Yatırımcı.AI Research TeamLast reviewed: Method: MethodologyEditorial policy